AHA comments on the Food and Drug Administrations draft Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA letter to Representative Fred Upton regarding his discussion draft of legislation on Advancing Telehealth Opportunities in Medicare."
AHA responds to Representative Joseph Pitts' Graduate Medical Education open letter.